Specialty business services · Industrials · Fiscal year ends Oct 31
ABM Industries reported revenue of $8.7B in the fiscal year ended Oct 2025, up 4.6% from the year before. Operating income was $312M, an operating margin of 3.6%, and net income was $162M. Operating cash flow of $234M less capital expenditure of $79M left free cash flow of $155M. Net debt was $1.5B.
Ranks among the 21 specialty business services companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 6,229 | 7,807 | 8,096 | 8,359 | 8,746 |
| Cost of revenue | 5,258 | 6,758 | 7,038 | 7,326 | 7,671 |
| Gross profit | 970 | 1,049 | 1,059 | 1,034 | 1,075 |
| Selling, general & admin | 719 | 628 | 573 | 765 | 697 |
| Operating income | 206 | 349 | 410 | 212 | 312 |
| Interest expense | 28.6 | 41.1 | 82.3 | 85.0 | 96.4 |
| Pre-tax income | 180 | 310 | 331 | 134 | 220 |
| Income tax | 53.5 | 79.6 | 79.7 | 52.2 | 57.6 |
| Net income | 126 | 230 | 251 | 81.4 | 162 |
| Diluted EPS | 1.86 | 3.41 | 3.79 | 1.28 | 2.59 |
| Diluted shares | 68.0 | 67.5 | 66.3 | 63.6 | 62.7 |
| Fiscal year | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 62.8 | 73.0 | 69.5 | 64.6 | 104 |
| Receivables | 1,137 | 1,279 | 1,365 | 1,384 | 1,471 |
| Current assets | 1,401 | 1,561 | 1,711 | 1,789 | 1,939 |
| Net PP&E | 112 | 125 | 132 | 151 | 177 |
| Goodwill | 2,229 | 2,486 | 2,491 | 2,576 | 2,591 |
| Total assets | 4,436 | 4,869 | 4,934 | 5,097 | 5,270 |
| Payables | 289 | 316 | 299 | 324 | 401 |
| Deferred revenue | 58.5 | 46.3 | 90.1 | 63.7 | 74.7 |
| Current liabilities | 1,286 | 1,353 | 1,218 | 1,348 | 1,306 |
| Short-term debt | 31.4 | 182 | 31.5 | 31.6 | 29.4 |
| Long-term debt | 853 | 1,086 | 1,280 | 1,302 | 1,537 |
| Total liabilities | 2,827 | 3,152 | 3,134 | 3,315 | 3,484 |
| Shareholders' equity | 1,609 | 1,717 | 1,800 | 1,782 | 1,786 |
| Backlog (remaining obligations) | – | – | 333 | 259 | 235 |
| Fiscal year | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 314 | 20.4 | 243 | 227 | 234 |
| Capital expenditure | 34.3 | 50.8 | 52.6 | 59.4 | 79.3 |
| Free cash flow | 280 | −30.4 | 191 | 167 | 155 |
| Depreciation & amortisation | 89.9 | 112 | 121 | 107 | 106 |
| Stock-based compensation | 33.5 | 30.5 | 30.5 | 30.0 | 38.0 |
| Acquisitions | 710 | 195 | 0.0 | 114 | – |
| Share buybacks | 0.0 | 97.5 | 138 | 56.1 | 122 |
| Dividends paid | 51.0 | 51.9 | 57.5 | 56.5 | 65.6 |
| Dividend per share | 0.76 | 0.78 | 0.88 | 0.90 | 1.06 |
| Fiscal year | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 25.3% | 3.7% | 3.2% | 4.6% |
| Operating income growth (YoY) | – | 69.1% | 17.4% | −48.2% | 47.0% |
| EPS growth (YoY) | – | 83.3% | 11.1% | −66.2% | 102.3% |
| Gross margin | 15.6% | 13.4% | 13.1% | 12.4% | 12.3% |
| Operating margin | 3.3% | 4.5% | 5.1% | 2.5% | 3.6% |
| Net margin | 2.0% | 3.0% | 3.1% | 1.0% | 1.9% |
| Return on equityBlank when equity is negative | 7.8% | 13.4% | 14.0% | 4.6% | 9.1% |
| ROCEEBIT ÷ (assets − current liabilities) | 6.5% | 9.9% | 11.0% | 5.7% | 7.9% |
| Free cash flow margin | 4.5% | −0.4% | 2.4% | 2.0% | 1.8% |
| Cash conversion (CFO ÷ net income) | 2.49x | 0.09x | 0.97x | 2.79x | 1.44x |
| Receivable days | 67 | 60 | 62 | 60 | 61 |
| Payable days | 20 | 17 | 16 | 16 | 19 |
| Interest cover | 7.21x | 8.49x | 4.98x | 2.49x | 3.23x |
| Debt ÷ equity | 0.55x | 0.74x | 0.73x | 0.75x | 0.88x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 821 | 1,195 | 1,242 | 1,269 | 1,462 |
| Current ratio | 1.09x | 1.15x | 1.40x | 1.33x | 1.48x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.